Tracking Renal Tumors After Cryoablation Evaluation

Stopped early

Conditions studied: Kidney Neoplasms

In brief

TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.

Key facts

Study ID

NCT01117779

Run by

Boston Scientific Corporation

People needed

246

Starts

2010-07-09

Expected to finish

2020-11-24

Last updated by the study team

2024-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California Irvine — Orange, California, United States
• Kaiser Permanente — Denver, Colorado, United States
• University of Kentucky — Lexington, Kentucky, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Columbia University — New York, New York, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.